MDRNA, Inc. Issued Patent for the Use of Nucleic Acids to Treat Cancer

News   Jan 27, 2010

 
MDRNA, Inc. Issued Patent for the Use of Nucleic Acids to Treat Cancer
 
 
 

RELATED ARTICLES

Quotient Sciences Acquires Pharmaterials, a UK-based Contract Development and Manufacturing Organization

News

Quotient Sciences, the drug development services organization, announces it has acquired Pharmaterials, a contract development and manufacturing organization (CDMO) based in Reading, U.K..

READ MORE

Electron Backscatter Diffraction Yields Microstructure Insights

News

Researchers have created an advanced characterization method to closely examine microscale structural characteristics and changes during manufacturing processes using electron backscatter diffraction.

READ MORE

Prostate- and Colon Cancer Targeted With Tapeworm Drug

News

Recently researchers found that a substance in medicine against parasites like Giardia and Tapeworms, acts like tailored medicine against prostate- and colon cancer.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Applied Sciences Drug Discovery Genomics Research Microfluidics Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE